(Q46174216)

20 December 2017

title

Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgery (English)

1 reference

20 December 2017

0 references

1 reference

Deric M Park

1

1 reference

20 December 2017

Dhvani D Shah

series ordinal

2

1 reference

20 December 2017

Merrill J Egorin

series ordinal

3

1 reference

20 December 2017

Jan H Beumer

series ordinal

4

1 reference

20 December 2017

publication date

6 January 2009

1 reference

20 December 2017

Journal of Neuro-Oncology

published in

1 reference

20 December 2017

volume

93

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

279-283

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s11060-008-9773-4

exact match

0 references

cites work

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-008-9773-4

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration

21 January 2018

1 reference

12 December 2020

Temozolomide in the treatment of solid tumours: current results and rationale for dosing/scheduling

1 reference

12 December 2020

Disposition of imatinib and its metabolite CGP74588 in a patient with chronic myelogenous leukemia and short-bowel syndrome

1 reference

12 December 2020

Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients

1 reference

12 December 2020

Decreased cyclosporine absorption after treatment with GoLytely lavage solution in a kidney transplant patient

1 reference

12 December 2020

Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients

1 reference

12 December 2020

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.

1 reference

12 December 2020

Pharmacokinetics of oral valganciclovir and intravenous ganciclovir administered to prevent cytomegalovirus disease in an adult patient receiving small-intestine transplantation

1 reference

12 December 2020

Low plasma level of all-trans retinoic acid after feeding tube administration for acute promyelocytic leukemia

1 reference

12 December 2020

Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer

1 reference

12 December 2020

Population pharmacokinetics of temozolomide in cancer patients

1 reference

12 December 2020

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

1 reference

12 December 2020

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 reference

12 December 2020

Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide

1 reference

12 December 2020

High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma

1 reference

12 December 2020

1 reference

12 December 2020

Systemic absorption of oral fluconazole after gastrointestinal resection

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

10.1007/S11060-008-9773-4

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017